These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20507648)

  • 21. Hypercalcemia in a woman with hypoparathyroidism associated with increased parathyroid hormone-related protein during lactation.
    Shomali ME; Ross DS
    Endocr Pract; 1999; 5(4):198-200. PubMed ID: 15251676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children.
    Demir K; Döneray H; Kara C; Atay Z; Çetinkaya S; Çayır A; Anık A; Eren E; Uçaktürk A; Can Yılmaz G; Törel Ergür A; Kendirci M; Aycan Z; Bereket A; Aydın M; Orbak Z; Özkan B
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):140-148. PubMed ID: 30396880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PROLONGED VITAMIN D INTOXICATION IN A PATIENT WITH HYPOPARATHYROIDISM.
    SPAULDING WB; YENDT ER
    Can Med Assoc J; 1964 May; 90(18):1049-54. PubMed ID: 14146852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
    Stamp TC
    Curr Med Res Opin; 1981; 7(5):316-36. PubMed ID: 6894416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercalcemia and acute renal insufficiency following use of a veterinary supplement.
    Ronsoni MF; Santos HCD; Colombo BDS; Correa CG; Moritz APG; Coral MHC; Sande-Lee SV; Hohl A
    J Bras Nefrol; 2017; 39(4):467-469. PubMed ID: 29319776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortisol-dihydrotachysterol antagonism in a patient with hypoparathyroidism and adrenal insufficiency: apparent inhibition of bone resorption.
    Farrell PM; Rikkers H; Moel D
    J Clin Endocrinol Metab; 1976 May; 42(5):953-7. PubMed ID: 1270584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolites and analogues of vitamin D. Which for what?
    Haussler MR; Cordy PE
    JAMA; 1982 Feb; 247(6):841-4. PubMed ID: 6895767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
    Kanis JA; Russell RG
    Br Med J; 1977 Jan; 1(6053):78-81. PubMed ID: 832019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of vitamin D3, dihydrotachysterol, and parathormone on calcium kinetics in the rat.
    Remagen W; Guncaga J; Lauffenburger T
    Res Exp Med (Berl); 1975 Sep; 165(3):285-90. PubMed ID: 169559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dihydrotachysterol poisoning].
    Müller G; Mendler E
    Z Gesamte Inn Med; 1984 Oct; 39(20):511-3. PubMed ID: 6516495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism.
    Jansson S; Morgan E
    World J Surg; 2004 Dec; 28(12):1293-7. PubMed ID: 15517486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypo and hypercalcemia as an emergency].
    Haas HG; Dambacher MA; Guncaga J
    Klin Wochenschr; 1975 May; 53(10):451-9. PubMed ID: 1104994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone.
    Gucalp R; Theriault R; Gill I; Madajewicz S; Chapman R; Navari R; Ahmann F; Zelenakas K; Heffernan M; Knight RD
    Arch Intern Med; 1994 Sep; 154(17):1935-44. PubMed ID: 8074597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypercalcemic activity of dihydrotachysterol-2 and dihydrotachysterol-3 and of the vitamins D2 and D3 after intravenous injection of the aqueous preparations. 2. Comparative experiments on rats.
    ROBORGH JR; de MAN T
    Biochem Pharmacol; 1960 Jul; 3():277-82. PubMed ID: 14438012
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S; Kratzsch J; Paschke R; Koch CA
    Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile secretion in acute and chronic hypercalcemia in the cat.
    Layer P; Hotz J; Sinewe S; Goebell H
    Dig Dis Sci; 1986 Feb; 31(2):188-92. PubMed ID: 3002737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.
    Chatterjee M; Speiser PW
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1241-8. PubMed ID: 18183797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of hypoparathyroidism during pregnancy--report of twelve cases.
    Callies F; Arlt W; Scholz HJ; Reincke M; Allolio B
    Eur J Endocrinol; 1998 Sep; 139(3):284-9. PubMed ID: 9758437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,25(OH)2D levels in dihydrotachysterol-treated patients: influence on 1,25(OH)2D assays.
    Taylor A; Norman ME
    J Bone Miner Res; 1987 Dec; 2(6):567-70. PubMed ID: 2844067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.